rs1000728174
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_006904.7(PRKDC):c.2112T>A(p.Phe704Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000033 in 1,574,826 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_006904.7 missense
Scores
Clinical Significance
Conservation
Publications
- severe combined immunodeficiency due to DNA-PKcs deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: ClinGen, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PRKDC | ENST00000314191.7 | c.2112T>A | p.Phe704Leu | missense_variant | Exon 19 of 86 | 1 | NM_006904.7 | ENSP00000313420.3 | ||
| PRKDC | ENST00000338368.7 | c.2112T>A | p.Phe704Leu | missense_variant | Exon 19 of 85 | 1 | ENSP00000345182.4 | |||
| PRKDC | ENST00000541488.1 | n.51T>A | non_coding_transcript_exon_variant | Exon 1 of 3 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152268Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000103 AC: 2AN: 193946 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.0000344 AC: 49AN: 1422558Hom.: 0 Cov.: 30 AF XY: 0.0000298 AC XY: 21AN XY: 703710 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152268Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74402 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.2112T>A (p.F704L) alteration is located in exon 19 (coding exon 19) of the PRKDC gene. This alteration results from a T to A substitution at nucleotide position 2112, causing the phenylalanine (F) at amino acid position 704 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Severe combined immunodeficiency due to DNA-PKcs deficiency Uncertain:1
This sequence change replaces phenylalanine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 704 of the PRKDC protein (p.Phe704Leu). This variant is present in population databases (no rsID available, gnomAD 0.002%). This variant has not been reported in the literature in individuals affected with PRKDC-related conditions. ClinVar contains an entry for this variant (Variation ID: 541990). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt PRKDC protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
PRKDC-related disorder Uncertain:1
The PRKDC c.2112T>A variant is predicted to result in the amino acid substitution p.Phe704Leu. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0024% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at